News

Presentation topics will include therapies for age-related macular degeneration, X-linked retinitis pigmentosa and other retinal pathologies

Jeremiah Tao, MD, FACS, used his Egyptian Ophthalmological Society keynote to explore complex and costly challenges in oculofacial surgery

Clinical leaders including Susan Schneider, MD; Lejla Vajzovic, MD; and Harvey Uy, MD, will share new clinical findings

An understanding of GA growth kinetics is key to addressing the pathophysiology of age-related macular degeneration

Where to find members of our editorial board at this year's European Society of Retina Specialists Congress

Answering all the questions ophthalmologists may have ahead of the EURETINA Congress in Paris, France

New support offers a streamlined experience for surgeons and patients

The clinical support system integrates artificial intelligence into OCT interpretation workflow

Patients with higher exposure to nature and green spaces were significantly less likely to experience dry eye, investigators reported

The province's public health insurance scheme, Régie de l’assurance maladie du Québec (RAMQ), covers faricimab for three indications

Surgical microscopes have undergone significant changes over the past decade, moving from conventional optics toward digital platforms that redefine the boundaries of surgical visualization. My own transition from the ARTEVO® 800 (Carl Zeiss Meditec AG, Jena, Germany) to the ARTEVO® 850 microscope has provided a firsthand perspective on how these advancements translate into real-world clinical benefit—particularly in the management of vitreoretinal surgery.

A 12-month follow-up indicated no dose limiting toxicity and no ocular or systemic adverse effects

Every day brings a new challenge for surgeons in low-resource areas and conflict zones

Salvation of ocular tissues and visual acuity are dependent on early diagnosis, investigators emphasised

Highlights from the 2025 Heidelberg Engineering International SPECTRALIS Symposium—And Beyond

New financing will support the company's lead retinitis pigmentosa programme, among other projects

Consistent trends across prevalence, incidence, odds and time-to-event models suggest ocular mitochondrial disease may indicate neurodegenerative risk

Sandoz will hold exclusive or semi-exclusive marketing rights in several European and Asian countries

An ophthalmologic examination revealed bilateral anterior uveitis, though the patient had no ocular complaints at presentation

João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases

The transaction is anticipated to close in 6 to 12 months subject to customary closing conditions and regulatory approval

In a press release, the National Institute for Health and Care Excellence announced the first-ever approval for a mitochondrial disease treatment

GLP-1 therapies could impact long-term outcomes in diabetic retinopathy

Can AI compete with the well-oiled machine of the contemporary clinic?

Enhanced screenings and a unified registry could save vision and lives

The Global RDH12 Alliance unites inherited retinal disease advocacy groups including UK-based Eyes on the Future and the US-based RDH12 Fund for Sight

The IRIS is a cloud-based model that supports artificial intelligence-assisted diabetic retinopathy screening